Sulfapyridine (polymorph III), sulfapyridine dioxane solvate,sulfapyridine tetrahydrofuran solvate and sulfapyridine piperidine solvate,all at 173 K

The X‐ray crystal structures of solvates of sulfapyridine have been determined to be conformational polymorphs. 4‐Amino‐N‐(1,2‐dihydropyridin‐2‐ylidene)benzenesulfonamide (polymorph III), C₁₁H₁₁N₃O₂S, (1), 4‐amino‐N‐(1,2‐dihydropyridin‐2‐ylidene)benzenesulfonamide 1,3‐dioxane monosolvate, C₁₁H₁₁N₃O₂S·C₄H₈O₂, (2), and 4‐amino‐N‐(1,2‐dihydropyridin‐2‐ylidene)benzenesulfonamide tetrahydrofuran monosolvate, C₁₁H₁₁N₃O₂S·C₄H₈O, (3), crystallized as the imide form, while piperidin‐1‐ium 4‐amino‐N‐(pyridin‐2‐yl)benzenesulfonamidate, C₅H₁₂N⁺·C₁₁H₁₀N₃O₂S⁻, (4), crystallized as the piperidinium salt. The tetrahydrofuran and dioxane solvent molecules in their respective structures were disordered and were refined using a disorder model. Three‐dimensional hydrogen‐bonding networks exist in all structures between at least one sulfone O atom and the aniline N atom.     

The heteroscorpionate ligand 2,2‐bis(3,5‐dimethylpyrazol‐1‐yl)‐1,1‐diphenylethanol and an easy preparation of its tungsten complex

The heteroscorpionate ligand 2,2‐bis(3,5‐dimethylpyrazol‐1‐yl)‐1,1‐diphenylethanol, C₂₄H₂₆N₄O, features in the solid state an intramolecular O—H…N hydrogen bond. A heteroscorpionate tungsten complex, cis‐[2,2‐bis(3,5‐dimethylpyrazolyl)‐1,1‐diphenylethanolato]chloridodioxidotungsten(VI) tetrahydrofuran monosolvate, [W(C₂₄H₂₅N₄O)ClO₂]·C₄H₈O, was prepared by the simple mixing of solutions of the ligand and WOCl₄ in tetrahydrofuran. The tungsten complex was isolated after standing for several weeks. The complex exhibits a κ³N,N′,O‐coordination of the ligand. This simple synthetic procedure allows access to the cis isomer in high yield without additional purification steps. The Hirshfeld surface analysis shows a change of the intermolecular contacts due to the coordination of the WO₂Cl unit with the ligand molecule.     

Pyridine and 3‐methylpyridine solvates of the triple sulfa drug constitutent sulfamethazine

Sulfonamides display a wide variety of pharmacological activities. Sulfamethazine [abbreviated as SMZ; systematic name 4‐amino‐N‐(4,6‐dimethylpyrimidin‐2‐yl)benzenesulfonamide], one of the constitutents of the triple sulfa drugs, has wide clinical use. Pharmaceutical solvates are crystalline solids of active pharmaceutical ingredients (APIs) incorporating one or more solvent molecules in the crystal lattice, and these have received special attention, as the solvent molecule can impart characteristic physicochemical properties to APIs and solvates, therefore playing a significant role in drug development. The ability of SMZ to form solvates has been investigated. Both pyridine and 3‐methylpyridine form solvates with SMZ in 1:1 molar ratios. The pyridine monosolvate, C₁₂H₁₄N₄O₂S·C₅H₅N, crystallizes in the orthorhombic space group Pna 2₁, with Z = 8 and two molecules per assymetric unit, whereas the 3‐methylpyridine monosolvate, C₁₂H₁₄N₄O₂S·C₆H₇N, crystallizes in the orthorhombic space group P 2₁2₁2₁, with Z = 4. Crystal structure analysis reveals intramolecular N—H…N hydrogen bonds between the molecules of SMZ and the pyridine solvent molecules. The solvent molecules in both structures play an active part in strong intermolecular interactions, thereby contributing significantly to the stability of both structures. Three‐dimensional hydrogen‐bonding networks exist in both structures involving at least one sulfonyl O atom and the amine N atom. In the pyridine solvate, there is a short π–π interaction [centroid–centroid distance = 3.926 (3) Å] involving the centroids of the pyridine rings of two solvent molecules and a weak intermolecular C—H…π interaction also contributes to the stability of the crystal packing.     

Three new olanzapine structures: the acetic acid monosolvate,and the propan‐2‐ol and propan‐2‐one hemisolvate monohydrates

The crystal structures of three new solvates of olanzapine [systematic name: 2‐methyl‐4‐(4‐methylpiperazin‐1‐yl)‐10H‐thieno[2,3‐b][1,5]benzodiazepine], namely olanzapine acetic acid monosolvate, C₁₇H₂₀N₄S·C₂H₄O₂, (I), olanzapine propan‐2‐ol hemisolvate monohydrate, C₁₇H₂₀N₄S·0.5C₃H₈O·H₂O, (II), and olanzapine propan‐2‐one hemisolvate monohydrate, C₁₇H₂₀N₄S·0.5C₃H₆O·H₂O, (III), are presented and compared with other known olanzapine forms. There is a fairly close resemblance of the molecular conformation for all studied analogues. The crystal structures are built up through olanzapine dimers, which are characterized via C—H...π interactions between the aliphatic fragment (1‐methylpiperazin‐4‐yl) and the aromatic fragment (benzene system). All solvent (guest) molecules participate in hydrogen‐bonding networks. The crystal packing is sustained via intermolecular N_host—H...O_guest, O_guest—H...N_host, O_guest—H...O_guest and C_host—H...O_guest hydrogen bonds. It should be noted that the solvent propan‐2‐ol in (II) and propan‐2‐one in (III) show orientational disorder. The propan‐2‐ol molecule lies close to a twofold axis, while the propan‐2‐one molecule resides strictly on a twofold axis through the carbonyl C atom. In both cases, the water molecules present positional disorder of the H atoms.     

Structural comparison of group 7 tricarbonyl complexes of 2‐{[2‐(1H‐imidazol‐4‐yl)ethyl]iminomethyl}‐5‐methylphenolate

Two tricarbonyl complexes of rhenium(I) and manganese(I) coordinated by the ligand 2‐{[2‐(1H‐imidazol‐4‐yl)ethyl]iminomethyl}‐5‐methylphenolate are reported, viz. fac‐tricarbonyl(2‐{[2‐(1H‐imidazol‐4‐yl‐κN³)ethyl]iminomethyl‐κN}‐5‐methylphenolato‐κO)rhenium(I) methanol monosolvate, [Re(C₁₆H₁₄N₃O₄)(CO)₃]·CH₃OH, (I), and fac‐tricarbonyl(2‐{[2‐(1H‐imidazol‐4‐yl‐κN³)ethyl]iminomethyl‐κN}‐5‐methylphenolato‐κO)manganese(I), fac‐[Mn(C₁₆H₁₄N₃O₄)(CO)₃], (II), display facial coordination in a distorted octahedral environment. The crystal structure of (I) is stabilized by O—H...O, N—H...O and C—H...O hydrogen‐bond interactions, while that of (II) is stabilized by N—H...O hydrogen‐bond interactions only. These interactions result in two‐dimensional networks and π–π stacking for both structures.     

A twofold interpenetrating two‐dimensional zinc(II) coordination polymer: synthesis,crystal structure and physical properties

A novel twofold interpenetrating two‐dimensional (2D) Zn^II coordination framework, poly[[(μ‐1,3‐bis(2‐methyl‐1H‐imidazol‐1‐yl)benzene‐κ²N³:N³)(μ‐naphthalene‐2,6‐dicarboxylato‐κ²O²:O⁶)zinc(II)] dimethylformamide monosolvate], {[Zn(C₁₂H₆O₄)(C₁₄H₁₄N₄)]·C₃H₇NO}_n or {[Zn(1,3‐BMIB)(NDC)]·DMF}_n (I), where H₂NDC is naphthalene‐2,6‐dicarboxylic acid, 1,3‐BMIB is 1,3‐bis(2‐methyl‐1H‐imidazol‐1‐yl)benzene and DMF is dimethylformamide, was prepared and characterized through IR spectroscopy, elemental analysis, thermal analysis and single‐crystal X‐ray diffraction. Single‐crystal X‐ray diffraction analysis revealed that (I) exhibits an unusual twofold interpenetrating 2D network. In addition, it displays strong fluorescence emissions and a high photocatalytic activity for the degradation of Rhodamine B (RhB) under UV‐light irradiation.     

Synthesis and characterization of a novel long‐alkyl‐chain ester‐substituted benzimidazole gelator and its octan‐1‐ol solvate

The synthesis of a novel benzimidazole derivative with a long‐chain‐ester substituent, namely methyl 8‐[4‐(1H‐benzimidazol‐2‐yl)phenoxy]octanoate, (3), is reported. Ester (3) shows evidence of aggregation in solution and weak gelation ability with toluene. The octan‐1‐ol solvate, methyl 8‐[4‐(1H‐benzimidazol‐2‐yl)phenoxy]octanoate octan‐1‐ol monosolvate, C₂₂H₂₆N₂O₃·C₈H₁₈O, (4), exhibits a four‐molecule hydrogen‐bonded motif in the solid state, with N—H…O hydrogen bonds between benzimidazole molecules and O—H…N hydrogen bonds between the octan‐1‐ol solvent molecules and the benzimidazole unit. The alkyl chains of the ester and the octan‐1‐ol molecules are in unfolded conformations. The phenylene ring is canted by 10.27 (6)° from the plane of the benzimidazole ring system. H…C contacts make up 20.7% of the Hirshfeld surface coverage. Weak C—H…π interactions involving the benzimidazole alkyl chain and three aromatic rings are observed.     

Supramolecular architecture in azaheterocyclic phosphonates. III. Structures of an ethyl phosphonamidate and an ethyl phosphonate

The novel crystal structures of ethyl (S)‐P‐(4‐oxo‐4H‐benzo[4,5]thiazolo[3,2‐a]pyrimidin‐3‐yl)‐N‐[(R)‐1‐phenylethyl]phosphonamidate, C₂₀H₂₀N₃O₃PS, I , and diethyl (4‐isopropyl‐2‐oxo‐3,4‐dihydro‐2H‐benzo[4,5]thiazolo[3,2‐a]pyrimidin‐3‐yl)phosphonate, C₁₈H₂₅N₂O₄PS, II , were characterized by X‐ray diffraction analysis. The crystal packing of I is dominated by two infinite stacks composed of symmetry‐independent molecules linked by distinctively different hydrogen‐bond systems. The structure of II shows a ladder packing topology similar to those observed in related phosphorylated azaheterocycles. Structural studies are supplemented by calculations on the interactions stabilizing the molecular assemblies using the PIXEL method. Additionally, fingerprint plots derived from the Hirshfeld surfaces were generated for each structure to characterize the crystal packing arrangements in detail. The aromaticities of the heterocyclic moieties have been investigated using HOMA and HOMHED parametrization and compared with structures reported previously.     

Similar sulfonamides with different crystal structures: sulfasymazine and sulfatriazine

The crystal structures of 4‐amino‐N‐(4,6‐diethyl‐1,3,5‐triazin‐2‐yl)benzenesulfonamide, C₁₃H₁₇N₅O₂S, and 4‐amino‐N‐(4,6‐dimethoxy‐1,3,5‐triazin‐2‐yl)benzenesulfonamide, C₁₁H₁₃N₅O₄S, also known as sulfasymazine and sulfatriazine, respectively, are dominated by hydrogen‐bond interactions. All three potential hydrogen‐bond donors are employed in each case, resulting in a three‐dimensional network for sulfasymazine, while an entirely different hydrogen‐bonded layer structure is obtained for sulfatriazine. This study demonstrates the versatile nature of the hydrogen‐bonding capabilities in sulfonamides, even in structurally very similar molecules.     

Dinuclear cobalt and nickel complexes of a mercaptoacetic acid substituted 1,2,4‐triazole ligand: syntheses,structures and urease inhibitory studies

Because of its versatile coordination modes and strong coordination ability, the mercaptoacetic acid substituted 1,2,4‐triazole 2‐{[5‐(pyridin‐2‐yl)‐4H‐1,2,4‐triazol‐3‐yl]sulfanyl}acetic acid ( H₂L ) was synthesized and characterized. Treatment of H₂L with cobalt and nickel acetate afforded the dinuclear complexes {μ‐3‐[(carboxylatomethyl)sulfanyl]‐5‐(pyridin‐2‐yl)‐4H‐1,2,4‐triazol‐4‐ido‐κ²N¹,N⁵:N²,O}bis[aqua(methanol‐κO)cobalt(II)] methanol disolvate, [Co₂(C₉H₆N₄O₂S)₂(CH₃OH)₂(H₂O)₂]·2CH₃OH ( 1 ), and {μ‐3‐[(carboxylatomethyl)sulfanyl]‐5‐(pyridin‐2‐yl)‐4H‐1,2,4‐triazol‐4‐ido‐κ²N¹,N⁵:N²,O}bis[diaquanickel(II)] methanol disolvate dihydrate, [Ni₂(C₉H₆N₄O₂S)₂(H₂O)₄]·2CH₃OH·2H₂O ( 2 ), respectively. Complex 1 crystallized in the monoclinic space group P2₁/c, while 2 crystallized in the tetragonal space group I4₁/a. Single‐crystal X‐ray diffraction studies revealed that H₂L is doubly deprotonated and acts as a tetradentate bridging ligand in complexes 1 and 2 . For both of the obtained complexes, extensive hydrogen‐bond interactions contribute to the formation of their three‐dimensional supermolecular structures. Hirshfeld surface analysis was used to illustrate the intermolecular interactions. Additionally, the urease inhibitory activities of 1 , 2 and H₂L were investigated against jack bean urease, where the two complexes revealed strong urease inhibition activities.     

A concise and efficient synthesis of amino‐substituted (1H‐benzo[d]imidazol‐1‐yl)pyrimidine hybrids: synthetic sequence and the molecular and supramolecular structures of six examples

A concise and efficient synthesis of a series of amino‐substituted benzimidazole–pyrimidine hybrids has been developed, starting from the readily available N⁴‐(2‐aminophenyl)‐6‐methoxy‐5‐nitrosopyrimidine‐2,4‐diamine. In each of N⁵‐benzyl‐6‐methoxy‐4‐(2‐phenyl‐1H‐benzo[d]imidazol‐1‐yl)pyrimidine‐2,5‐diamine, C₂₅H₂₂N₆O, (I), 6‐methoxy‐N⁵‐(4‐methoxybenzyl)‐4‐[2‐(4‐methoxyphenyl)‐1H‐benzo[d]imidazol‐1‐yl]pyrimidine‐2,5‐diamine, C₂₇H₂₆N₆O₃, (III), 6‐methoxy‐N⁵‐(4‐nitrobenzyl)‐4‐[2‐(4‐nitrophenyl)‐1H‐benzo[d]imidazol‐1‐yl]pyrimidine‐2,5‐diamine, C₂₅H₂₀N₈O₅, (IV), the molecules are linked into three‐dimensional framework structures, using different combinations of N—H…N, N—H…O, C—H…O, C—H…N and C—H…π hydrogen bonds in each case. Oxidative cleavage of 6‐methoxy‐N⁵‐(4‐methylbenzyl)‐4‐[2‐(4‐methylphenyl)‐1H‐benzo[d]imidazol‐1‐yl]pyrimidine‐2,5‐diamine, (II), with diiodine gave 6‐methoxy‐4‐[2‐(4‐methylphenyl)‐1H‐benzo[d]imidazol‐1‐yl]pyrimidine‐2,5‐diamine, which crystallized as a monohydrate, C₁₉H₁₈N₆O·H₂O, (V), and reaction of (V) with trifluoroacetic acid gave two isomeric products, namely N‐{5‐amino‐6‐methoxy‐6‐[2‐(4‐methylphenyl)‐1H‐benzo[d]imidazol‐1‐yl]pyrimidin‐2‐yl}‐2,2,2‐trifluoroacetamide, which crystallized as an ethyl acetate monosolvate, C₂₁H₁₇F₃N₆O₂·C₄H₈O₂, (VI), and N‐{2‐amino‐6‐methoxy‐4‐[2‐(4‐methylphenyl)‐1H‐benzo[d]imidazol‐1‐yl]pyrimidin‐5‐yl}‐2,2,2‐trifluoroacetamide, which crystallized as a methanol monosolvate, C₂₁H₁₇F₃N₆O₂·CH₄O, (VIIa). For each of (V), (VI) and (VIIa), the supramolecular assembly is two‐dimensional, based on different combinations of O—H…N, N—H…O, N—H…N, C—H…O and C—H…π hydrogen bonds in each case. Comparisons are made with some related structures.     

Lamotriginium crotonate and lamotriginium salicylate ethanol monosolvate: the role of solvent molecules in the packing organization

Two lamotriginium salts, namely lamotriginium crotonate [systematic name: 3,5‐diamino‐6‐(2,3‐dichlorophenyl)‐1,2,4‐triazin‐2‐ium but‐2‐enoate, C₉H₈Cl₂N₅⁺·C₄H₅O₂⁻, (III)] and lamotriginium salicylate [systematic name: 3,5‐diamino‐6‐(2,3‐dichlorophenyl)‐1,2,4‐triazin‐2‐ium 2‐hydroxybenzoate ethanol monosolvate, C₉H₈Cl₂N₅⁺·C₇H₅O₃⁻·C₂H₅OH, (IV)] present extremely similar centrosymmetric hydrogen‐bonded A …L …L …A packing building blocks (L is lamotriginium and A is the anion). The fact that salicylate salt (IV) is (ethanol) solvated, while crotonate salt (III) is not, has a profound effect on the way these elemental units aggregate to generate the final crystal structure. Possible reasons for this behaviour are analyzed and the hypothesis raised checked against similar structures in the literature.     

The preparation,characterization, structure and dissolution analysis of apremilast solvatomorphs

Apremilast (AP) {systematic name: (S )‐2‐[1‐(3‐ethoxy‐4‐methoxyphenyl)‐2‐(methylsulfonyl)ethyl]‐4‐acetamidoisoindoline‐1,3‐dione} is an inhibitor of phosphodieasterase‐4 (PDE4) and is indicated for the treatment of adult patients with active psoriatic arthritis. The ability of AP to form solvates has been investigated and three solvatomorphs of AP, namely, the AP ethyl acetate hemisolvate, C₂₂H₂₄N₂O₇S·0.5C₄H₈O₂, the AP toluene hemisolvate, C₂₂H₂₄N₂O₇S·0.5C₇H₈, and the AP dichloromethane monosolvate, C₂₂H₂₄N₂O₇S·CH₂Cl₂, were obtained. The three AP solvatomorphs were characterized by X‐ray powder diffraction, thermogravimetric analysis and differential scanning calorimetry. Single‐crystal X‐ray diffraction was used to analyze the structures, crystal symmetry, packing modes, stoichiometry and hydrogen‐bonding interactions of the solvatomorphs. In addition, dissolution analyses were performed to study the dissolution rates of different AP solvatomorph tablets in vitro and to make comparisons with commercial apremilast tablets (produced by Celgene); all three solvatomorphs showed similar dissolution rates and similar values of the similarity factor f₂ in a comparison of their dissolution profiles.     

Structural studies and antileishmanial activity of 2‐acetylpyridine and 2‐benzoylpyridine nitroimidazole‐derived hydrazones

Three imidazole hydrazone compounds, namely 2‐(4‐nitro‐1H‐imidazol‐1‐yl)‐N′‐[1‐(pyridin‐2‐yl)ethylidene]acetohydrazide, C₁₂H₁₂N₆O₃, ( 1 ), 2‐(2‐nitro‐1H‐imidazol‐1‐yl)‐N′‐[1‐(pyridin‐2‐yl)ethylidene]acetohydrazide, C₁₂H₁₂N₆O₃, ( 2 ), and 2‐(2‐nitro‐1H‐imidazol‐1‐yl)‐N′‐[(phenyl)(pyridin‐2‐yl)methylidene]acetohydrazide, C₁₇H₁₄N₆O₃, ( 3 ), were obtained and fully characterized, including their crystal structure determinations. While all the compounds proved not to be cytotoxic to J774.A1 macrophage cells, ( 1 ) and ( 3 ) exhibited activity against Leishmania chagasi, whereas ( 2 ) was revealed to be inactive. Since both ( 1 ) and ( 3 ) exhibited antileishmanial effects, while ( 2 ) was devoid of activity, the presence of the acetyl or benzoyl groups was possibly not a determining factor in the observed antiprotozoal activity. In contrast, since ( 1 ) and ( 3 ) are 4‐nitroimidazole derivatives and ( 2 ) is a 2‐nitroimidazole‐derived compound, the presence of the 4‐nitro group probably favours antileishmanial activity over the 2‐nitro group. The results suggested that further investigations on compounds ( 1 ) and ( 3 ) as bioreducible antileishmanial prodrug candidates are called for.     

Three novel topologically different metal–organic frameworks built from 3‐nitro‐4‐(pyridin‐4‐yl)benzoic acid

The design and synthesis of metal–organic frameworks (MOFs) have attracted much interest due to the intriguing diversity of their architectures and topologies. However, building MOFs with different topological structures from the same ligand is still a challenge. Using 3‐nitro‐4‐(pyridin‐4‐yl)benzoic acid (HL) as a new ligand, three novel MOFs, namely poly[[(N,N‐dimethylformamide‐κO)bis[μ₂‐3‐nitro‐4‐(pyridin‐4‐yl)benzoato‐κ³O,O′:N]cadmium(II)] N,N‐dimethylformamide monosolvate methanol monosolvate], {[Cd(C₁₂H₇N₂O₄)₂(C₃H₇NO)]·C₃H₇NO·CH₃OH}_n, ( 1 ), poly[[(μ₂‐acetato‐κ²O:O′)[μ₃‐3‐nitro‐4‐(pyridin‐4‐yl)benzoato‐κ³O:O′:N]bis[μ₃‐3‐nitro‐4‐(pyridin‐4‐yl)benzoato‐κ⁴O,O′:O′:N]dicadmium(II)] N,N‐dimethylacetamide disolvate monohydrate], {[Cd₂(C₁₂H₇N₂O₄)₃(CH₃CO₂)]·2C₄H₉NO·H₂O}_n, ( 2 ), and catena‐poly[[[diaquanickel(II)]‐bis[μ₂‐3‐nitro‐4‐(pyridin‐4‐yl)benzoato‐κ²O:N]] N,N‐dimethylacetamide disolvate], {[Ni(C₁₂H₇N₂O₄)₂(H₂O)₂]·2C₄H₉NO}_n, ( 3 ), have been prepared. Single‐crystal structure analysis shows that the Cd^II atom in MOF ( 1 ) has a distorted pentagonal bipyramidal [CdN₂O₅] coordination geometry. The [CdN₂O₅] units as 4‐connected nodes are interconnected by L^? ligands to form a fourfold interpenetrating three‐dimensional (3D) framework with a dia topology. In MOF ( 2 ), there are two crystallographically different Cd^II ions showing a distorted pentagonal bipyramidal [CdNO₆] and a distorted octahedral [CdN₂O₄] coordination geometry, respectively. Two Cd^II ions are connected by three carboxylate groups to form a binuclear [Cd₂(COO)₃] cluster. Each binuclear cluster as a 6‐connected node is further linked by acetate groups and L^? ligands to produce a non‐interpenetrating 3D framework with a pcu topology. MOF ( 3 ) contains two crystallographically distinct Ni^II ions on special positions. Each Ni^II ion adopts an elongated octahedral [NiN₂O₄] geometry. Each Ni^II ion as a 4‐connected node is linked by L^? ligands to generate a two‐dimensional network with an sql topology, which is further stabilized by two types of intermolecular OW—HW…O hydrogen bonds to form a 3D supramolecular framework. MOFs ( 1 )–( 3 ) were also characterized by powder X‐ray diffraction, IR spectroscopy and thermogravimetic analysis. Furthermore, the solid‐state photoluminescence of HL and MOFs ( 1 ) and ( 2 ) have been investigated. The photoluminescence of MOFs ( 1 ) and ( 2 ) are enhanced and red‐shifted with respect to free HL. The gas adsorption investigation of MOF ( 2 ) indicates a good separation selectivity (71) of CO₂/N₂ at 273 K (i.e. the amount of CO₂ adsorption is 71 times higher than N₂ at the same pressure).     

Structural and spectroscopic characterization of two new blue luminescent pyridylbenzimidazole zinc(II) complexes

Luminescent metal complexes are used in photooptical devices. Zinc(II) complexes are of interest because of the ability to tune their color, their high thermal stability and their favorable carrier transport character. In particular, some zinc(II) complexes with aryl diimine and/or heterocyclic ligands have been shown to emit brightly in the blue region of the spectrum. Zinc(II) complexes bearing derivatized imidazoles have been explored for possible optoelectronic applications. The structures of two zinc(II) complexes of 5,6‐dimethyl‐2‐(pyridin‐2‐yl)‐1‐[(pyridin‐2‐yl)methyl]‐1H‐benzimidazole (L), namely dichlorido(dimethylformamide‐κO){5,6‐dimethyl‐2‐(pyridin‐2‐yl‐κN)‐1‐[(pyridin‐2‐yl)methyl]‐1H‐benzimidazole‐κN³}zinc(II) dimethylformamide monosolvate, [ZnCl₂(C₂₀H₁₈N₄)(C₃H₇NO)]·C₃H₇NO, (I), and bis(acetato‐κ²O,O′){5,6‐dimethyl‐2‐(pyridin‐2‐yl‐κN)‐1‐[(pyridin‐2‐yl)methyl]‐1H‐benzimidazole‐κN³}zinc(II) ethanol monosolvate, [Zn(C₂H₃O₂)₂(C₂₀H₁₈N₄)]·C₂H₅OH, (II), are reported. Complex (I) crystallized as a dimethylformamide solvate and exhibits a distorted trigonal bipyramidal coordination geometry. The coordination sphere consists of a bidentate L ligand spanning axial to equatorial sites, two chloride ligands in equatorial sites, and an O‐bound dimethylformamide ligand in the remaining axial site. The other complex, (II), crystallized as an ethanol solvate. The Zn^II atom has a distorted trigonal prismatic coordination geometry, with two bidentate acetate ligands occupying two edges and a bidentate L ligand occupying the third edge of the prism. Complexes (I) and (II) emit in the blue region of the spectrum. The results of density functional theory (DFT) calculations suggest that the luminescence of L results from π*←π transitions and that the luminescence of the complexes results from interligand charge‐transfer transitions. The orientation of the 2‐(pyridin‐2‐yl) substituent with respect to the benzimidazole system was found to have an impact on the calculated HOMO–LUMO gap (HOMO is highest occupied molecular orbital and LUMO is lowest unoccupied molecular orbital).     

Structural characterization of a hybrid terpyridine–pyrazine ligand and its one‐dimensional ZnII coordination polymer: a computational approach to conventional and nonconventional intermolecular interactions

The structures of a new hybrid terpyridine–pyrazine ligand, namely 4′‐[4‐(pyrazin‐2‐yl)phenyl]‐4,2′:6′,4′′‐terpyridine (L2), C₂₅H₁₇N₅, and its one‐dimensional coordination polymer catena‐poly[[bis(acetylacetonato‐κ²O,O′)zinc]‐μ‐4′‐[4‐(pyrazin‐2‐yl‐κN⁴)phenyl]‐4,2′:6′,4′′‐terpyridine‐κN¹], [Zn(C₅H₇O₂)₂(C₂₅H₁₇N₅)]_n or [Zn(acac)₂(L2)]_n (Hacac is acetylacetone), are reported. Packing interactions in both crystal structures are analyzed using Hirshfeld surface and enrichment ratio techniques. For the simpler structure of the monomeric ligand, further studies on the interaction hierarchy using the energy framework approach were made. The result was a complete picture of the intermolecular interaction landscape, which revealed some subtle details, for example, that some weak (at first sight negligible) C—H…N interactions in the structure of free L2 play a relevant role in the crystal stabilization.     

Solvates of zafirlukast

The crystal structures of three solvates of zafirlukast [systematic name: cyclopentyl N‐{1‐methyl‐3‐[2‐methyl‐4‐(o‐tolylsulfonylaminocarbonyl)benzyl]‐1H‐indol‐5‐yl}carbamate], viz. the monohydrate, C₃₁H₃₃N₃O₆S·H₂O, (I), the methanol solvate, C₃₁H₃₃N₃O₆S·CH₃OH, (II), and the ethanol solvate, C₃₁H₃₃N₃O₆S·C₂H₅OH, (III), have been determined by single‐crystal X‐ray diffraction analysis. All three compounds crystallize in the monoclinic crystal system. Zafirlukast adopts a similar Z‐shaped conformation in all three solvates. The methanol and ethanol solvates are isostructural. The packing of the zafirlukast mol­ecules in all three crystal structures is similar and is expressed by hydrogen‐bonded mol­ecules that are related by translation, along (101) in (I) and along the b axis in (II) and (III). The methanol and ethanol solvent mol­ecules are hydrogen bonded to two mol­ecules of zafirlukast. The water mol­ecule, on the other hand, acts as a connector via hydrogen bonds between three mol­ecules of zafirlukast. The solvent mol­ecules are not released at temperatures below the melting points of the solvates.     

Diphenylalanine in tetrahydrofuran: a highly potent candidate for the development of novel nanomaterials

The peptide di‐l ‐phenylalanine (FF) has emerged as a highly potent candidate for the development of novel nanomaterials. The unprotected peptide was dissolved in 1,1,1,3,3,3‐hexafluoropropan‐2‐ol (HFIP) mixed with tetrahydrofuran (THF) and single crystals of the THF monosolvate, C₁₈H₂₀N₂O₃·C₄H₈O, were grown by slow evaporation in a `vial‐in‐closed‐bottle' system. THF is a molecule that can only act as a hydrogen‐bond acceptor. Thus, the hydrogen‐bond patterns observed in the crystal structures at 100 and 299 K are different compared to that of crystals grown from water and methanol [Mason et al. (2014). ACS Nano. 8 , 1243–1253].     

Hirshfeld surface analysis of two bendroflumethiazide solvates

Bendroflumethiazide, or 3‐benzyl‐6‐(trifluoromethyl)‐3,4‐dihydro‐2H‐1,2,4‐benzothiadiazine‐7‐sulfonamide 1,1‐dioxide, is reported to crystallize as 1:1 solvates with acetone, C₁₅H₁₄F₃N₃O₄S₂·C₃H₆O, and N,N‐dimethylformamide, C₁₅H₁₄F₃N₃O₄S₂·C₃H₇NO. A detailed investigation of the crystal packing and intermolecular interactions is presented by means of Hirshfeld surface analysis. This analysis confirms the atomic positions of methyl H atoms of the solvent molecules that were inferred from the X‐ray data and provides a useful tool for structure validation.